Search research articles
Contact Us
Filters
Showing results (201-210 of 294) with videos related to
Page
of 30
Sort By:
Journal of Human Hypertension
|
November 1, 2001
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics
P Uusimaa, H Tokola, H Ruskoaho, et al.
Acta Dermato-Venereologica
|
April 1, 1993
Effects of systemic isotretinoin on serum markers of collagen synthesis and degradation
P Autio, J Risteli, R Palatsi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement
|
January 1, 1991
Connective tissue metabolism and alcohol intake in alcoholic liver disease
O Niemelä, J Risteli, J E Blake, et al.
The European Respiratory Journal
|
March 11, 1998
Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
L Lammi, V Kinnula, S Lähde, et al.
Annals of the Rheumatic Diseases
|
August 25, 1999
The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study
S Aman, J Risteli, R Luukkainen, et al.
The British Journal of Dermatology
|
January 22, 2003
Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin
P Nuutinen, R Riekki, M Parikka, et al.
Annals of the Rheumatic Diseases
|
November 1, 1995
Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis
M Hakala, S Aman, R Luukkainen, et al.
The British Journal of Dermatology
|
February 1, 1992
Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen
A Oikarinen, P Autio, J Vuori, et al.
The British Journal of Dermatology
|
February 17, 1999
Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?
N Hunzelmann, J Risteli, L Risteli, et al.
The Journal of Pediatrics
|
April 17, 1998
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids
S Crowley, P Trivedi, L Risteli, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 294) with videos related to
Sort By:
Page
of 30
Journal of Human Hypertension
|
November 1, 2001
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics
P Uusimaa, H Tokola, H Ruskoaho, et al.
Acta Dermato-Venereologica
|
April 1, 1993
Effects of systemic isotretinoin on serum markers of collagen synthesis and degradation
P Autio, J Risteli, R Palatsi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement
|
January 1, 1991
Connective tissue metabolism and alcohol intake in alcoholic liver disease
O Niemelä, J Risteli, J E Blake, et al.
The European Respiratory Journal
|
March 11, 1998
Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
L Lammi, V Kinnula, S Lähde, et al.
Annals of the Rheumatic Diseases
|
August 25, 1999
The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study
S Aman, J Risteli, R Luukkainen, et al.
The British Journal of Dermatology
|
January 22, 2003
Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin
P Nuutinen, R Riekki, M Parikka, et al.
Annals of the Rheumatic Diseases
|
November 1, 1995
Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis
M Hakala, S Aman, R Luukkainen, et al.
The British Journal of Dermatology
|
February 1, 1992
Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen
A Oikarinen, P Autio, J Vuori, et al.
The British Journal of Dermatology
|
February 17, 1999
Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?
N Hunzelmann, J Risteli, L Risteli, et al.
The Journal of Pediatrics
|
April 17, 1998
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids
S Crowley, P Trivedi, L Risteli, et al.
Page
of 30